DualTreatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial Academic Article 2015 uri icon

authors

  • Pérez Molina J
  • Troya J
  • Mariño A
  • Antela A
  • Navarro J
  • Esteban H
  • Moreno S
  • GESIDA 7011 Study Group
  • Study Group Members (among then Gutierrez F and Masia M)
  • GUTIERREZ RODERO, FELIX
  • Rubio R
  • MASIA CANUTO, MARIA DEL MAR
  • Rivero A
  • Pasquau J
  • Suárez-Lozano I
  • Riera M
  • Estébanez M
  • Santos J
  • Sanz-Moreno J

publication date

  • 2015